M. Janine Jjingo is a corporate and finance attorney, primarily representing public and private corporations, as well as investment banks, commercial banks, private equity funds and financial institution investors in a wide range of U.S. and cross-border transactions. Ms. Jjingo frequently advises on secured and unsecured financings, acquisition financings, asset-backed loans, restructuring and debtor-in-possession financings, and other types of complex and traditional financings.


Ms. Jjingo regularly advises a variety of financial institutions, including Bank of America, Barclays, Citibank, Credit Suisse, Goldman Sachs, HSBC, ING and Morgan Stanley. Additionally, she counsels clients on a range of ESG-related matters.

In 2022, she was named one of Savoy Magazine’s Most Influential Black Lawyers and one of Crain’s New York Business’ Notable Diverse Leaders In Law, in addition to being named one of Lawdragon’s 500 Leading Lawyers in America and 500 Leading Dealmakers in America. Additionally, she has been recognized in The Best Lawyers in America, as a Rising Star in IFLR1000, a Rising Star in Finance at Euromoney Legal Media Group’s Americas Women in Business Law Awards and a Rising Star Best in Banking & Finance at Euromoney Legal Media Group’s Americas Rising Star Awards.

Her representations have included:

  • Adtalem Global Education Inc. in a new credit agreement that provided for $850 million of senior secured term B loans and a $400 million of revolving credit facility to finance its acquisition of Walden e-Learning, LLC from Laureate Education, Inc.;
  • Bank of America, N.A. as administrative agent in the extension of TreeHouse Foods, Inc.’s existing credit agreement, which provided for the amendment and extension of their existing $750 million revolving credit facility and $500 million term loan A facility, and an increase in the Tranche A-1 term loans from $900 million to $930 million;
  • Strongbridge Biopharma plc in its $267 million acquisition by Xeris Pharmaceuticals, Inc.;
  • NextEra Energy Resources, LLC, a subsidiary of NextEra Energy, Inc., in two transactions for $1.3 billion in total proceeds, which provided for its sale of a 90% interest in a 1,000-megawatt portfolio of long-term contracted wind and solar generation facilities and a 100% interest in a 100-MW solar-plus-storage project;
  • NextEra Energy Partners, LP in:
    • connection with its entry into a convertible equity portfolio financing arrangement with a fund managed by BlackRock Global Energy & Power Infrastructure; and
    • its $1.02 billion acquisition of a portfolio of 10 wind and solar projects, collectively consisting of 1,192 megawatts. In conjunction with the acquisition, NextEra Energy Partners also entered into a US$900 million convertible equity portfolio financing with a fund managed by Kohlberg Kravis Roberts & Co. L.P. This transaction was named Americas Power Deal of the Year by Project Finance International and Renewables Deal of the Year by Power Finance & Risk;
  • Visteon Corporation in various amendments to its credit agreement including the replacement and repricing of the existing term facility with a new $350 million term loan facility; and in the $3.6 billion sale of its 70% stake in Halla Visteon Climate Control Corp. (South Korea);
  • Key Safety Systems, Inc. in its $1.6 billion acquisition of substantially all of the assets and operations of Takata Corporation (Japan), as part of Takata’s Chapter 11 case;
  • BlackRock, Inc. in a variety of matters involving revolving credit facilities and its $20 billion acquisition of Barclays Global Investors;
  • Synergy Pharmaceuticals in its Chapter 11 filing, DIP financing and sale of substantially all of its assets to Bausch Health;
  • Pinnacle Entertainment, Inc. in its $2.8 billion acquisition by Penn National Gaming, Inc.;
  • DST Systems, Inc. in its $5.4 billion acquisition by SS&C Technologies Holdings, Inc.;
  • Permira Funds in connection with a first lien $325 million term loan and $50 million revolving facility, in addition to a second lien $120 million term loan to finance its acquisition of DiversiTech Holdings, Inc.;
  • Gilead in a variety of matters, including its $11.9 billion acquisition of Kite Pharma, Inc. and its $11 billion acquisition of Pharmasset, Inc.;
  • Valeant Pharmaceuticals International, Inc. in its:
    • $2.6 billion acquisition of Medicis Pharmaceutical Corporation;
    • $800 million acquisition of Mercury (Cayman) Holdings, the holding company of Amoun Pharmaceutical Company S.A.E. (Egypt); and
    • its $15 billion acquisition of Salix Pharmaceuticals Ltd.;
  • A&E Television Networks in connection with the financing of NBCUniversal Media, LLC’s $3 billion sale of its 15.8% stake in A&E to The Walt Disney Corporation and Hearst Corporation; and
  • E.I. DuPont de Nemours and Company in its:
    • $7.4 billion acquisition of Danisco A/S, a manufacturer of food ingredients; and
    • in a $3.5 billion revolving credit facility from JPMorgan Chase Bank, N.A.

Ms. Jjingo serves as hiring partner for Skadden’s New York office. She is a long-standing member of the firm’s Hiring Committee and previously co-chaired the Summer Associate Committee. She also heads the Summer Associate Banking Training Program and leads the Banking module of the Summer Associate M&A Training Program. In addition, Ms. Jjingo serves on Skadden’s Global Women’s Initiatives Committee.



  • J.D., Columbia Law School, 2005
  • B.A., University of Pennsylvania, 2002 (magna cum laude)


  • New York

M. Janine Jjingo